-
A new comprehensive wellness program put together by two companies with expertise in rehabilitation services and strength training does not leave self-motivation to chance. Instead, the program keeps older adults on the healthy path by addressing their total spiritual, medical, physical, and psychosocial needs.
-
Are you comfortable talking about return on investment? How about loss run analysis? Those business concepts may sound like someone elses job. But if you talk the language of the hospitals financial officers, you may win unprecedented support for your ergonomics program.
-
Do you want to increase satisfaction scores, improve patient care, and boost staff retention all in one shot? Consider switching to a team model of nursing.
-
If asked, How do you ensure patients are not mistakenly identified before medications are given? during an accreditation survey, would every nurse in your facility be able to answer the question?
-
Although drug-eluting stents were launched in Europe about a year prior to their introduction in the U.S., the market penetration of the devices in Europe is now significantly less than in the U.S. As discussed at the EuroPCR meeting (formerly the Paris Course on Revascularization), held here in mid-May, the slow trend in adoption is mainly attributable to reimbursement policies in a number of countries that cap the amount paid by the national health system at a level below that which would allow hospitals to use drug-eluting stents on all patients.
-
Listening to the heart with a stethoscope is the most widely used method for the detection of heart murmurs, but Zargis Medical (Princeton, New Jersey) has developed an auscultatory device it hopes will become the new standard of care.
-
The American Association for Clinical Chemistry (AACC; Washington), publisher of Lab Tests Online, a web site for laboratory testing information, has launched a second version of the site in the United Kingdom.
-
Escalon Medical (Wayne, Pennsylvania) said it revised its initial exchange offer for the shares of Drew Scientific Group (London), a company specializing in analytical systems for laboratory testing worldwide.
-
In a nearly unanimous vote, an FDA panel voted last month to oppose new labeling sought by WorldHeart (Ottawa, Ontario) for its Novacor LVAS (left ventricular assist system) for use with very sick heart-failure patients. The panel said WorldHeart did not present enough evidence to show the device would let those sicker patients improve enough to receive a heart transplant.
-
Cardiocom (Minneapolis, Minnesota) reported that Ucare Minnesota, a non-profit health maintenance organization, renewed its multi-year agreement with the disease management company to provide systems for remote daily home monitoring of Ucares congestive heart failure (CHF) patients.
